The Kelley Advantage
Coming from one of the leading business schools in the nation, CBLS has established a vehicle for you to learn from and interact with life sciences industry experts. The proof - 24 conferences organized since 2006.
Collaboration Conference Speaker Presentations
2012-13 Conference Series
- Conference Summary
- AM Panel Presentation- New Approaches to Working With Industry From the Midwest CTSI Consortium
- Anantha Shekhar, MD, Dean of Translational Research, IU School of Medicine
- James E. Heubi, MD, Associate Dean for Clinical and Translational Research, University of Cincinnati College of Medicine
- Marc K. Drezner, MD, Executive Director, Institute for Clinical and Translational Research, University of Wisconsin-Madison
- PM Panel Presentation – Challenges and Best Practices for Tech Transfers
- Guy Cook, Founder, Bacterin International & One World Group Ltd.
- Lawrence Bruder, President & CEO, Noxilier, Inc.
- Eric Thieme, General Counsel & Compliance Officer, Indiana Health Information Exchange
- Conference Summary
- Keynote Presentation - Medical Device Regulatory Reform and the FDA Safety and Innovation Act
- Janet Trunzo, Senior Executive Vice President, Technology and Regulatory Affairs, AdvaMed
- Panel Presentations - Expected Changes From the Recent FDA and Innovation Act
- Wendy Turner, Group Director, Regulatory Operations, Johnson & Johnson Global Surgery Group
- Dr. Robert Metcalf, Vice President Global Regulatory Affairs- U.S., Eli Lilly & Company
- Kelly Davis, Associate Director of Regulatory Affairs, Baxter BioPharma
- Tim Gee, Connected Health Specialist, The Anson Group & Principal at Medical Connectivity Consulting
- Keynote Presentation - Working with the FDA from the Inside Out
- Dr. Susan Alpert, Principal, SFA Consulting & former Director of the Office of Device Evaluation, FDA
- Panel Presentations - New Initiatiaves to Make the Agency More Effective and Efficient
2011-12 Conference Series
- Conference Summary
- Keynote Presentation - Emerging trends in Healthcare
Brian Williams, Director, Global Healthcare, PwC - Panel Presentation - Threading the Regulatory Needle Panel
- Enabling Personalized Medicine: Regulatory Considerations for Diagnostics
Christine Gathers, Senior Director, Global Regulatory Affairs Diagnostic, Eli Lilly & Company - Medical Device Interoperability: A critical enabler for personalized medicine
Scott Thiel, Senior Regulatory Consultant, The Anson Group, LLC - IVD Companion Diagnostic Devices
Chris Henza, Regulatory Affairs Specialist, Regulatory Compliance Associates Inc. - Companion Diagnostics: What Pharma Needs to Know About IVDs
David Kern, Senior Director, Myraqa Inc.
- Keynote Presentation - Fitting the Treatment to the Patient-Roche Personalized Healthcare
Mark Rutledge, Director of Marketing, Molecular Diagnostics, Roche Diagnostics
- Keynote Presentation - Helping Consumers Understand the Risks and Benefits of Medical Treatments
Dena Cox, PhD, Professor of Marketing and Faculty Fellow, Indiana University, Kelley School of Business – Indianapolis Anthony D. Cox, PhD, Professor of Marketing and Faculty Fellow Indiana University, Kelley School of Business – Indianapolis - Panel - “Tales from the Front” – Latest Industry Experiences in Medical Marketing
Bill McKee, State Government Strategy & Relations, Roche Diagnostics - Keynote Presentation - Today's Empowered Consumer: The State of Digital Health in 2011
Meredith Ressi, President, Manhattan Research - Panel - Consumer Participatory Medicine and Its Impact on Life Sciences Marketing
2010-11 Conference Series
- Panel- New Product Reviews and Approvals
- Panel- Current Business Operations
- Panel - “The Present” from a Providers’ and Payors’ Perspective
- Panel - “The Future”
2009-10 Conference Series
- Overview- Personalized Medicine: Health and IT Enablers -
Charles Kennedy, MD, Vice President, Health Information Technology, Wellpoint, Inc. - Keynote Address - Personalized Medicine: The Big Picture
John C. Lechleiter, PhD, Chairman, President and CEO, Eli Lilly and Company - Panel - The Science Behind the Business of Personalized Medicine
- Jane F. Barlow, MD, MPH, MBA, Vice President, Medical Strategy & Clinical Quality, Personalized Medicine, Solutions, Medco, Inc.
- Personalized Medicine: A View From the Trenches -
George W. Sledge, Jr., MD, Ballve-Lantero Professor, IU School of Medicine & Clinical Team Member, Indiana University Melvin and Bren Simon Cancer Center - Tissue Vaccines: New Approaches to Treatment of Cancer
Mark A. Suckow, DVM, Director, Freimann Life Science Center, Research Associate Professor, Department of Biological Sciences, University of Notre Dame
- Lunch Presentation - Medicine Will Become: Predictive, Personalized, Preventive and Participatory
Leroy Hood, M.D., PhD, President, Institute for Systems Biology - Panel - Personalized Medicine Business Start-ups: Lessons from the Field
- Tiffany Olson, Vice President of Diagnostics, Eli Lilly and Company
- Unique Approach to Targeted Therapeutics and Personalized Medicine
P. Ron Ellis, President, Endocyte, Inc. - Companion Diagnostics, Inc. In Partnership with Center for Translational Medicine IUPUI, Sony DADC, Life Technologies
Richard H. Selinfreund, PhD, President, Companion Diagnostics, Inc. - Academic Discovery Translating to Commercial Applications in Cancer Diagnosis and Therapies
Linda H. Malkas, PhD, Founder, CS-Keys, Inc. and Syntherix, Inc.
- Panel - Act III: Strategic Sourcing: Where Do We Turn for Help?
2008-09 Conference Series
- Panel: Perspectives from Asia, Europe, and the US: A Multijurisdictional Panel
